EUVIMEDEUVIMED entdecken
EditorialOpen Access

Targeting the kappa opioid receptor for analgesia and antitumour effects

David G Lambert, Joshua S Mincer

British Journal of Anaesthesia · 2025

DOI: 10.1016/j.bja.2024.10.014 ↗

Kurz gefasst

Editorial in der Zeitschrift British Journal of Anaesthesia, 2025. Verfasst von David G Lambert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Hodgkin Building, Leicester, UK. Hauptthemen laut MEDLINE: Analgesia, Analgesics, Opioid, Antineoplastic Agents, Glioma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Cancer Institute, National Institutes of Health, Memorial Sloan Kettering Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kappa opioid (KOP) receptor agonists have analgesic actions in a range of models, but central side-effects can limit their utility. In addition, non-analgesic actions of opioid receptors are receiving significant research interest. A recent article reports that high KOP receptor expression in glioma tissue correlates with improved survival and that KOP receptor agonism further promotes apoptosis of glioma cells through regulation of the p38 MAPK oncogenic pathway. This suggests that KOP receptor ligands could be developed as chemotherapeutic adjuncts in addition to their use as analgesics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnalgesiaAnalgesics, OpioidAntineoplastic AgentsGliomaReceptors, Opioid, kappaAnimalsHumans

Stichwörter der Autor:innen

analgesiakappa opioid receptoropioidtumour biology

Substanzen

Analgesics, OpioidAntineoplastic AgentsReceptors, Opioid, kappa

Autor:innen und Institutionen

  • Department of Cardiovascular Sciences, Anaesthesia, Critical Care and Pain Management, University of Leicester, Hodgkin Building, Leicester, UK.
  • Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA. Electronic address: mincerj@ms…

Förderung

  • National Cancer Institute
  • National Institutes of Health
  • Memorial Sloan Kettering Cancer Center

Zitieren

APA

Lambert, D. G., & Mincer, J. S. (2025). Targeting the kappa opioid receptor for analgesia and antitumour effects. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2024.10.014

Vancouver

Lambert DG, Mincer JS. Targeting the kappa opioid receptor for analgesia and antitumour effects. British Journal of Anaesthesia. 2025. doi:10.1016/j.bja.2024.10.014

BibTeX
@article{Lambert2025,
  author = {Lambert, David G and Mincer, Joshua S},
  title = {Targeting the kappa opioid receptor for analgesia and antitumour effects},
  journal = {British Journal of Anaesthesia},
  year = {2025},
  doi = {10.1016/j.bja.2024.10.014}
}
Kostenlos starten →